Annu Navani, Annu Navani, MD, FIPP, ABIPP, DABRM

Dr. Annu Navani is the Chief Medical Officer at Reve Health Institute, where she leads advanced regenerative and longevity medicine programs integrating precision medicine, cellular regeneration, and age-optimization science. A board-certified specialist in Pain and Regenerative Medicine, she is recognized for pioneering innovative, evidence-based therapies that enhance healthspan and functional longevity. She is the Founder of the World Institute of Regenerative Medicine (WIRM), a global platform uniting clinicians, scientists, and innovators to advance regenerative and longevity medicine. Dr. Navani is also the current President of the American Society of Interventional Pain Physicians (ASIPP), a 28-year-old leading national medical organization dedicated to advancing the science, education, advocacy, and evidence-based practice of interventional pain medicine to improve the care of patients with acute and chronic pain.
In academia, Dr. Navani has served for over two decades as Adjunct Clinical Faculty at Stanford University, where she has contributed to research and education in cutting-edge therapeutic innovations. She also serves as Chief Medical officer of Boomerang Healthcare, where she guides multidisciplinary spine, orthopedic and musculoskeletal care out of 22 locations in California. She completed her Anesthesiology residency at the Medical College of Wisconsin and Fellowship in Pain Medicine at the University of California, Davis. She is double board-certified in Pain Medicine and Regenerative Medicine.
Dr. Navani has been recognized with multiple honors, including the Outstanding Achievement Awards from various national and international professional organizations and has published extensively including several national clinical guidelines, and books.
Widely regarded as an influencer and authority in emerging medical technologies, Dr. Navani’s expertise spans digital health, applied biologics, and innovation in global healthcare systems, where she continues to shape the future of regenerative and longevity medicine.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:09/04/2026Date updated:09/04/2026

Facebook
X
LinkedIn
Forward